TROPHOCAN CVS CATHETER 4870-26

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a 00,05 report with the FDA on 1998-01-30 for TROPHOCAN CVS CATHETER 4870-26 manufactured by Sims Portex, Inc..

Event Text Entries

[123020] The patient experienced spotting, then bleeding and spontaneously aborted the fetus which had a possible ventral wall defect. The patient spiked a fever and required a d&c.
Patient Sequence No: 1, Text Type: D, B5


[7767022] This follow-up report consists of additional information provide by the user facility. Any unk entry throughout this form indicates that this information is unknown because it was not recorded at the user facility.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1217052-1998-00004
MDR Report Key146369
Report Source00,05
Date Received1998-01-30
Date of Event1997-09-03
Date Mfgr Received1998-01-02
Date Added to Maude1998-02-02
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag0
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location0
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameTROPHOCAN CVS CATHETER
Generic NameCATHETER, SAMPLING, CHORIONIC VILLUS
Product CodeLLX
Date Received1998-01-30
Model NumberNA
Catalog Number4870-26
Lot NumberUNK
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrR
Implant FlagN
Date Removed*
Device Sequence No1
Device Event Key142664
ManufacturerSIMS PORTEX, INC.
Manufacturer Address10 BOWMAN DR. KEENE NH 03431 US
Baseline Brand NameTROPHOCAN CVS CATHETER
Baseline Generic NameCATHETER, SAMPLING, CHORIONIC VILLUS
Baseline Model NoNA
Baseline Catalog No4870-26
Baseline IDNA
Baseline Device FamilyNA
Baseline Shelf Life ContainedY
Baseline Shelf Life [Months]60
Baseline PMA FlagY
Premarket ApprovalP8900
Baseline 510K PMNN
Baseline PreamendmentN
Baseline TransitionalN
510k ExemptN


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 1998-01-30

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.